降解剂向蛋白质无处不在性的机制
Charlotte Crowe1,2, Mark A Nakasone1,2, Sarah Chandler3
1Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, 1 James Lindsay Place, Dundee DD1 5JJ, UK.
Science advances
|October 11, 2024
概括
小分子降解剂利用E3酶来消除疾病蛋白质. 这项研究揭示了MZ1降解器如何将Brd4定位为无处不在,确定了对目标降解至关重要的关键氨酸残留物.
科学领域:
- 生物化学 生化学
- 结构生物学 结构生物学
- 药物发现 药物发现 药物发现
背景情况:
- 小分子降解剂是一种有前途的治疗策略,针对疾病驱动蛋白质.
- 了解通过降解剂介导复合体的标泛化机制对于药物开发至关重要.
研究的目的:
- 阐明小分子降解剂的目标泛化结构和机制基础.
- 为了确定关键的残留物和参与目标蛋白Brd4BD2的无处不在的区域.
主要方法:
- 低温电子显微镜 (cryo-EM) 用于确定VHL-Cullin 2 RING E3结合酶复合体与降解剂MZ1的结构,并准Brd4BD2.
- 在体外无处不在的测定和质谱测试以绘制无处不在的氨酸残留物.
- 细胞降解试验和无处不在学术以验证关键氨酸残留物 in vivo.
主要成果:
- 冷-EM结构揭示了Brd4BD2的精确定位,用于由UBE2R1-ubiquitin.
- Brd4BD2上的一个特定的"无处不在区域",包括Lys456,Lys368和Lys445,被确定为降解的关键.
- 该研究强调了降解剂的催化效率和E3结合酶复合物的灵活性.
结论:
- 提出了一种机制模型,用于降解剂招募的目标的无处不在.
- 这些发现为合理设计更有效的小分子降解剂提供了蓝图.
- 这项研究促进了我们对向蛋白质降解机制的理解.
相关概念视频
02:58Regulated Protein Degradation
7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
01:13The Proteasome
816
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
816
01:17The Proteasome Structure
712
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
712
02:04Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
01:15Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
01:32Export of Misfolded Proteins out of the ER
3.5K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.5K